| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is making significant strides in product development, particularly in the realm of obesity treatments, with promising prospects for FDA approval on new drugs. Their innovative approach, especially with Tirzepatide, indicates a strong focus on addressing growing health concerns related to obesity and diabetes. Additionally, the company is exploring growth opportunities beyond its traditional GLP-1 products, enhancing its portfolio through new partnerships in the biotech sector. This proactive strategy suggests a positive outlook for continued innovation and market relevance. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 1 is bullish. The market sentiment at 1.1 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.1, and the negative at -0 on 2025-11-10. The forces of Sentiment towards Fundamentals (3.8), Market Risk Appetite (1), Sector Price Trend (1), Stock Price Trend (1), Option Sentiment (0), and Price Level Sentiment (0) will drive up the price. The forces of and Valuation Sentiment (-0.1) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-10 | 0%(0%) | 1 | 0.25% | 1 | 3.8 | 5.5 | |||||||
| 2025-11-09 | 0%(0%) | 1 | 0.25% | 1.1 | 3.8 | 7 | |||||||
| 2025-11-08 | 0%(0%) | 1 | 0.25% | 1.1 | 3.8 | -1 | |||||||
| 2025-11-07 | 0%(0%) | 1 | 0.25% | 0.9 | 3.7 | 6 | |||||||
| 2025-11-06 | 0%(0%) | 1 | 0.25% | 0.9 | 3.9 | 0.3 | |||||||
| 2025-11-05 | 0%(0.1%) | 1 | 0.25% | 1 | 4.7 | -1 | |||||||
| 2025-11-04 | 0%(0.1%) | 1 | 0.25% | 1 | 4.7 | 5.3 | |||||||
| 2025-11-03 | 0%(0.1%) | 1 | 0.25% | 1.1 | 4.8 | -1 | |||||||
| 2025-11-02 | 0%(0.1%) | 1 | 0.25% | 1 | 4.7 | -1 | |||||||
| 2025-11-01 | 0%(0.1%) | 1 | 0.25% | 1 | 4.6 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-10 17:49:53 The collaboration with upstart biotech players indicates a strategic move to strengthen market position. |
| 2025-11-10 17:49:53 Eli Lilly is expanding its offerings by forming partnerships with new biotech firms. |
| 2025-11-10 17:02:13 The partnerships and projects within the biopharma industry indicate a competitive landscape with a focus on revolutionary treatments. |
| 2025-11-10 17:02:13 Eli Lilly's financial commitment to new therapeutic options signifies a trend of increased investment in innovative healthcare solutions. |
| 2025-11-10 17:02:13 The development of new gene therapies reflects continuous innovation and investment in product advancement in the biopharmaceutical field. |
| 2025-11-10 17:02:13 The collaboration between Eli Lilly and MeiraGTx highlights a strategic partnership to advance gene therapy for severe eye diseases. |
| 2025-11-10 17:02:13 The increase in Eli Lilly's stock price indicates positive market sentiment and confidence in the company's current status. |
| 2025-11-10 13:49:55 The forecast for an additional 19% gain in shares suggests positive expectations regarding stock valuation. |
| 2025-11-10 13:49:55 The landmark deal with the U.S. government signifies a strong partnership that is likely to enhance the company's prospects. |
| 2025-11-10 13:49:55 The article discusses an upgrade from an analyst, indicating positive sentiment towards the company's stock performance. |